MannKind Corp (NASDAQ:MNKD)

research

Major Biotech Is So-So for Short Sellers

The short interest data are out for the March 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
intelinside

The Most Shorted Nasdaq Stocks List Now Topped by Intel

Intel rose to the top of the list of the most heavily shorted stocks traded on the Nasdaq between the February 27 and March 13 settlement dates, displacing Sirius XM. ...
Read Full Story »
Biotechnology word cloud

Short Sellers Get More Aggressive on Big Biotech

The short interest data are out for the February 27 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Sirius Logo

10 Most Shorted Nasdaq Stocks List Still Topped by Sirius XM

Despite a shrinking number of shares short in many of them, the usual suspects remain at the top of the list of the most heavily shorted stocks traded on the ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AK Steel, AmEx, Citi, MannKind, Micron, Ocwen, Seagate and More

Stocks were indicated marginally lower on Tuesday after the Nasdaq hit 5,000 for the first time in 15 years. If there is one trend that has prevailed without fail for ...
Read Full Story »
Biotechnology word cloud

4 Biotechs Expected to See Huge Buying on PowerShares Rebalance

All the major money management firms that run exchange traded funds have to do regular quarterly rebalances to reset their portfolios to the proper allocation levels. When they do rebalance ...
Read Full Story »
research

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The short interest data are out for the February 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
intelchip

The 5 Most Shorted Nasdaq Stocks in February

There was no change in the ranking of the most heavily shorted stocks traded on the Nasdaq in early February, even though Frontier Communications and Advanced Micro Devices both saw ...
Read Full Story »
Biotechnology word cloud

Short Sellers Look Scared of Big Biotech

The short interest data are out for the January 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Sirius Logo

The 5 Nasdaq Stocks With the Most Shares Short

In late January, Sirius XM reclaimed its top spot among the most heavily shorted stocks traded on the Nasdaq, even though its short interest increased only marginally. The number of ...
Read Full Story »
Biotechnology word cloud

Short Sellers Starting to Gang Up on Biotech

The short interest data are out for the January 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
NASDAQ_stock_market

The 5 Most Shorted Nasdaq Stocks in Early January

Advanced Micro Devices joined the most heavily shorted stocks changing hands on the Nasdaq as the new year got underway. Before that it was listed on the New York Stock ...
Read Full Story »
Biotechnology word cloud

Short Interest in Biotechs Signals Optimism

The short interest data are out for the December 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Sirius Logo

The 5 Most Shorted Nasdaq Stocks at the End of 2014

Among the most heavily shorted stocks changing hands on the Nasdaq as last year wound to a close, BlackBerry, Comcast and Sirius XM saw their short interest rise somewhat. However, ...
Read Full Story »
DNA

6 Serious Biotech and Health Care Movers

In Thursday morning’s trading session, it seemed almost across the board that biotech stocks were the largest gainers. The broad markets were signaling optimism Thursday after a lackluster week, and ...
Read Full Story »